Doxepin Rivopharm 25 mg
Doxepin Rivopharm 25 mg is a medicine authorised by Swissmedic under authorisation number 69433. The authorisation holder is Rivopharm SA. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 23 July 2024 and the authorisation is limited until 22 July 2029. ATC code N06AA12 places the medicine in the group Psychoanaleptics.
| Authorisation number | 69433 |
|---|---|
| Name | Doxepin Rivopharm 25 mg |
| Full name | Doxepin Rivopharm 25 mg, capsule rigide |
| Authorisation holder | Rivopharm SA |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | N06AA12 |
| First authorisation | 23 July 2024 |
| Authorisation validity | 22 July 2029 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Doxepin Rivopharm 25 mg, capsule rigide | B | 23 July 2024 |
| 2 | Doxepin Rivopharm 50 mg, capsule rigide | B | 23 July 2024 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 28 | Kapsel(n) | N06AA12 | 01.06.0. | B |
| 2 | 98 | Kapsel(n) | N06AA12 | 01.06.0. | B |
| 3 | 28 | Kapsel(n) | N06AA12 | 01.06.0. | B |
| 4 | 98 | Kapsel(n) | N06AA12 | 01.06.0. | B |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Doxepin Rivopharm 25 mg authorised in Switzerland?
Yes. Doxepin Rivopharm 25 mg is authorised by Swissmedic under authorisation number 69433, data as of 01 September 2026. The authorisation is limited until 22 July 2029.
Which dispensing category does Doxepin Rivopharm 25 mg have?
Doxepin Rivopharm 25 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Doxepin Rivopharm 25 mg?
The authorisation holder is Rivopharm SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.